Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis

Rhea-AI Summary

Aurora (NASDAQ: ACB) will ring the Nasdaq closing bell on Wednesday, February 18, 2026 at Nasdaq MarketSite in Times Square. The ceremony begins with a live broadcast at 3:45 p.m. ET and the bell will ring at 4:00 p.m. ET.

CEO and Executive Chairman Miguel Martin will lead the event alongside board and executive representatives to highlight Aurora's medical-first, global cannabis strategy and progress in international markets.

Key Figures

Bell-ringing date: February 18, 2026 Announcement date: February 12, 2026 Broadcast start time: 3:45 p.m. ET +5 more

8 metrics

Bell-ringing date February 18, 2026 Nasdaq closing bell ceremony

Announcement date February 12, 2026 Press release publication date

Broadcast start time 3:45 p.m. ET Nasdaq closing bell live broadcast

Bell time 4:00 p.m. ET Scheduled Nasdaq closing bell ring

Current price $3.455 Pre-news market context for ACB

52-week low $3.28 Lower bound of last 52 weeks

52-week high $6.83 Upper bound of last 52 weeks

Market cap $201,885,549 Equity value before bell-ringing news

Market Reality Check

Price: $3.37 Vol: Volume 607,752 is below t...

low vol

$3.37 Last Close

Volume Volume 607,752 is below the 20-day average of 1,254,579 (about 0.48x typical activity). low

Technical Shares at 3.455 trade below the 200-day MA of 4.81 and sit close to the 52-week low of 3.28, roughly halfway down from the 6.83 52-week high.

Peers on Argus

ACB fell 3.37% with several healthcare/cannabis peers also negative: OGI -7.09%,...

ACB fell 3.37% with several healthcare/cannabis peers also negative: OGI -7.09%, IRWD -4.31%, LFCR -2.69%, SXTC -2.35%, TKNO -0.47%, indicating a broader sector risk-off backdrop rather than a company-specific move tied to the bell-ringing news.

Historical Context

5 past events · Latest: Feb 04 (Negative)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 04	ATM equity program	Negative	-7.6%	Filed prospectus supplement for up to U.S.$100M at-the-market offering.
Feb 04	Quarterly results	Positive	-7.6%	Q3 FY2026 results with revenue growth and strong global medical contribution.
Feb 03	European websites	Positive	+3.6%	Launched localized European medical cannabis websites and central hub.
Jan 21	Earnings call setup	Neutral	+2.1%	Announced schedule and details for Q3 2026 investor conference call.
Jan 20	EU IP protection	Positive	-2.1%	Secured EU Community Plant Variety Rights for two proprietary cannabis strains.

Pattern Detected

Recent news has often seen mixed follow-through, with positive strategic/financial updates sometimes met by negative price reactions.

Recent Company History

Over the last few weeks, Aurora reported Q3 FY2026 results with higher net revenue and record global medical cannabis sales on Feb 4, yet shares fell 7.64% after that and an at-the-market equity program announcement the same day. Earlier in February, new European medical-focused websites on Feb 3 saw a 3.57% gain. In January, scheduling the Q3 call (Jan 21) and securing EU plant variety rights (Jan 20) produced modest, mixed reactions. Today’s Nasdaq bell event fits the ongoing narrative of a medical-first, globally focused strategy.

Market Pulse Summary

This announcement highlights Aurora’s intent to showcase its evolution into a medical-first, globall...

Analysis

This announcement highlights Aurora’s intent to showcase its evolution into a medical-first, globally focused cannabis company via the Nasdaq closing bell on February 18, 2026. In recent months, the company reported Q3 FY2026 net revenue of $94.2M, launched new European medical websites, and secured EU plant variety rights, while also initiating an at-the-market equity program. With shares trading near the 52-week low of 3.28 and below the 200-day MA of 4.81, investors may watch future medical growth, capital raises, and international traction closely.

AI-generated analysis. Not financial advice.

                                                                              NASDAQ | TSX: ACB

EDMONTON, AB, Feb. 12, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces the company will ring the Nasdaq closing bell on Wednesday, February 18, 2026, at the Nasdaq MarketSite in New York's Times Square.

The ceremony will be led by Aurora's CEO and Executive Chairman, Miguel Martin, alongside a representative of the company's Board of Directors, executive leadership team and other employees. This event celebrates Aurora's evolution into a medical-first, globally focused cannabis company and strengthened position in key international markets.

"As we advance our global medical strategy, this moment at Nasdaq underscores our longstanding commitment to serving patients worldwide," said Miguel Martin, CEO & Executive Chairman for Aurora. "Our medical business is the clear driver of Aurora's growth and today's milestone reflects the tremendous progress we've made in opening the world to cannabis, and the exciting opportunities still ahead."

The Closing Bell ceremony will be broadcast live beginning at 3:45 p.m. ET, with the bell scheduled to ring at 4:00 p.m. ET, and streamed across Nasdaq's official channels. To view the live broadcast, visit: https://www.nasdaq.com/marketsite/bell-ringing-ceremony.

About Aurora 

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves both medical and consumer markets across Canada, Europe, Australia, and New Zealand, with a strategic focus on high-margin opportunities and a medical-first approach. Aurora's portfolio of trusted, leading brands includes Aurora^®, MedReleaf^®, Pedanios^®, IndiMed^™, San Raf^®, Tasty's^® and Whistler Medical Marijuana Co.^®. The company also holds a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis^™.  

Learn more at www.auroramj.com and follow us on X and LinkedIn. 

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB". 

Forward Looking Information  

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the Company's upcoming Nasdaq bell-ringing ceremony, the advancement of the Company's global medical cannabis strategy, the medical cannabis business as a driver of growth for the Company, and future growth opportunities. 

These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from Canada into the United States; the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 17, 2025  (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-to-ring-the-nasdaq-closing-bell-on-wednesday-february-18-2026-reinforcing-strategic-focus-on-global-medical-cannabis-302686833.html

SOURCE Aurora Cannabis Inc.

FAQ

When will Aurora (ACB) ring the Nasdaq closing bell on February 18, 2026?

The bell will ring at 4:00 p.m. ET on February 18, 2026. According to the company, a live broadcast begins at 3:45 p.m. ET from Nasdaq MarketSite in Times Square and will stream across Nasdaq's official channels.

Who will represent Aurora (ACB) at the Nasdaq closing bell on February 18, 2026?

Aurora's CEO and Executive Chairman Miguel Martin will lead the ceremony. According to the company, he will be joined by a board representative, members of the executive leadership team, and other employees.

How can investors watch Aurora's (ACB) Nasdaq closing bell ceremony on February 18, 2026?

Investors can view the ceremony via Nasdaq's livestream beginning at 3:45 p.m. ET. According to the company, the broadcast will stream across Nasdaq's official channels and the Nasdaq MarketSite bell-ringing webpage.

What is the significance of Aurora (ACB) ringing the Nasdaq closing bell on February 18, 2026?

The event highlights Aurora's shift to a medical-first, global cannabis focus. According to the company, the ceremony underscores progress in international markets and commitment to serving patients worldwide.

Will Aurora's (ACB) Nasdaq bell ceremony on February 18, 2026 affect trading or stock listings?

The bell ceremony is a symbolic investor relations event and does not change trading or listings. According to the company, it is intended to mark strategic progress rather than alter market or regulatory status.